Introduction
============

There are two types of diabetes mellitus. Type 1 diabetes is caused by the lack of insulin secretion resulting from an autoimmune destruction of insulin-secreting pancreatic β cells.[@b1-ppa-9-649] Management of type 1 diabetes is mainly by exogenous insulin replacement, including insulin analogs depending on each patient's severity of insulin deficiency. Type 2 diabetes is initially caused by insulin resistance, which is closely related to the accumulation of abdominal fat resulting from overeating, the lack of exercise, relative insulin deficiency, first phase insulin defect, and incretin deficiency.[@b2-ppa-9-649] The standard treatment for type 2 diabetes is dietary therapy and appropriate exercise, followed by sequential addition of oral antihyperglycemic agents, GLP-1 receptor agonists, or insulin injection (basal and/or mealtime).[@b3-ppa-9-649] Large prospective clinical studies show a strong relationship between glycemia and diabetic micro-vascular complications in both type 1 and type 2 diabetes.[@b4-ppa-9-649],[@b5-ppa-9-649] However, modification of lifestyle habits, as well as adherence to pharmacological treatment, proves to be challenging in many patients.[@b6-ppa-9-649]--[@b8-ppa-9-649] It remains unclear why many patients with diabetes cannot make the necessary lifestyle changes and cannot adhere to pharmacological treatment, both of which are obviously beneficial for their future health.

The theory of neuroeconomics, an emerging field of study dealing with anomalies of the classical economics rationale, can provide important clues for understanding unreasonable human behavior concerning decisions between outcomes occurring at different time points.[@b9-ppa-9-649] Neuroeconomics studies have demonstrated that humans and animals prefer rewards with short-term availability over rewards with long-term availability.[@b8-ppa-9-649],[@b9-ppa-9-649] A recent report by economists investigating rational models of addiction indicated that those who emphasize future rewards and those who give more importance to rewards that are certain were significantly more likely to continue to abstain from smoking.[@b10-ppa-9-649] Using an analogy, investigating personal attitude toward risks may provide important information for the treatment of patients with diabetes, especially for difficult-to-treat patients. However, to date, there has been no study analyzing behavior in patients with diabetes from a neuroeconomics perspective. In the present study, we conducted the first behavioral economics survey of patients with type 1 and type 2 diabetes to determine whether patients who are at a risk of developing complications are less risk averse. On the other hand, in our preliminary study, we found that patients with type 2 diabetes with poor glycemic control tended to avoid answering questions dealing with decision making in hypothetical situations. Therefore, we also examined whether patients with type 1 and type 2 diabetes have different behavioral traits in terms of decision making under risk.

Patients and methods
--------------------

All the patients (487 patients) with diabetes treated by an endocrinologist at the outpatient clinic of endocrinology at Nippon Medical School Chiba Hokusoh Hospital from November 2012 to April 2013 were included in this study. The hospital is one of three local base hospitals in a rural area of Japan with a population of 700,000. The clinic provides care to patients with diabetes who have been referred by general practitioners or other departments in the hospital because of poor metabolic control or unstable complications. Of the 487 patients, 268 were excluded because of psychiatric disease, mental retardation, dementia, active malignant disease, unstable endocrine disease, or refusal to participate in the survey. Therefore, 219 outpatients were eligible for the behavioral economics survey, 66 with type 1 diabetes and 153 with type 2 diabetes. Patients with type 1 diabetes were defined as those with acute onset of insulin-dependent diabetes or positive anti-glutamic acid decarboxylase or anti-islet antigen-2 antibodies. All other patients were defined as having type 2 diabetes. The survey and an explanation sheet that included a consent form were handed out at the outpatient clinic. Participants also received a book coupon worth 500 yen (JPY 500= USD 5) as a token remuneration. The completed survey forms were returned by mail. The survey questionnaire used in this study is shown in [Table 1](#t1-ppa-9-649){ref-type="table"}. The first nine questions were modified from the Japan Household Survey on Consumer Preferences and Satisfaction (QA--QI),[@b11-ppa-9-649],[@b12-ppa-9-649] and the others were developed specifically for the present study (QJ--QQ). The HbA~1c~ levels were determined by high-performance liquid chromatography using HLC723G8 (Tosoh, Co., Tokyo, Japan) and presented as the equivalent National Glycohemoglobin Standardization Program values. To evaluate retinopathy, ophthalmologists performed fundoscopy after pupillary dilatation, based on the Davis classification:[@b13-ppa-9-649] no diabetic retinopathy, simple diabetic retinopathy, preproliferative diabetic retinopathy, and proliferative diabetic retinopathy, including panretinal photocoagulation. Nephropathy was defined as urinary albumin excretion ≥30 mg/g creatinine or estimated glomerular filtration rate \<30 mL/min/1.73 m^2^. The survey results and patient data were compared and analyzed. The study protocol, including the consent form with a confidentiality clause, was approved by the Internal Review Board of the Nippon Medical School Chiba-Hokusoh Hospital Ethics Committee.

Statistical analyses
====================

Statistical analyses were performed using JMP^®^ 11 (SAS Institute Inc., Cary, NC, USA). Continuous variables were compared using the Student's *t*-test, Welch's *t*-test, or Mann--Whitney *U*-test. Stratified comparisons were performed using the Mantel--Haenszel procedure. Frequency analysis was performed using the Fisher's exact probability test and the McNemar's chi-square test. The relationship between continuous variables was investigated using Spearman's rank correlation coefficient. Multiple logistic regression analysis was used to select answers significantly associated with diabetic complications.

Results
=======

Patient characteristics
-----------------------

Age-stratified characteristics of patients investigated in this study are shown in [Table 2](#t2-ppa-9-649){ref-type="table"}. Levels of HbA~1c~ were not significantly different between patients with type 1 and type 2 diabetes in any age category. Diabetes duration was significantly shorter in young (under 45 years of age) patients with type 2 diabetes. Body mass index (BMI) and prevalence of nephropathy and retinopathy were significantly higher in middle-aged (45--under 65 years of age) patients with type 2 diabetes. Furthermore, in young patients, the sex ratio differed between patients with type 1 and type 2 diabetes, with more females than males in the type 1 diabetes group. Therefore, we performed stratified analysis according to age and sex, when necessary.

Survey response rate
--------------------

The survey response rate in patients with type 2 diabetes was significantly lower than that in patients with type 1 diabetes (71.9% vs 87.9%, [Table 3](#t3-ppa-9-649){ref-type="table"}). Age-stratified analysis using the Mantel--Haenszel test confirmed that the response rate in patients with type 2 diabetes was significantly lower than that in patients with type 1 diabetes (*P*\<0.01).

Logistic regression analysis of factors associated with complications
---------------------------------------------------------------------

Before logistic regression analysis, we examined statistical correlation between responses to the questionnaires. QE (lottery 1 low risk, low gain) and QF (lottery 2 high risk, high gain) were significantly correlated (*P*\<0.01). QH (myopic time preference 1) was also significantly correlated with QI (myopic time preference 2) (*P*\<0.01). Therefore, we eliminated QF and QI from the logistic regression analysis in order to avoid multicollinearity. We also removed QD (procrastination 2) because of apparent correlation with QC (procrastination 1).

[Table 4](#t4-ppa-9-649){ref-type="table"} shows the results of logistic regression analysis of factors associated with retinopathy. The model produced a good fit for the data given the statistical significance of the likelihood-ratio chi-square test (*P*\<0.0001). In the standard logit results (Wald test), the parameters of diabetes type, diabetes duration, levels of HbA~1c~, hypothetical lottery risk estimation (low risk, low gain) (QE), myopic time preference (QH), willingness to pay for medicine (QM), and levels of satisfaction with life (QN) showed statistical significance. According to the estimate, type 1, myopic time preference, and willingness to pay for a medicine reducing disease risk were negatively associated with progression of retinopathy. On the other hand, diabetes duration, HbA~1c~, and risk seeking (pricing higher) in hypothetical lottery (QE) were positively associated with retinopathy. Patients who selected very in QE (general satisfaction to current life) had no retinopathy or only simple diabetic retinopathy.

[Table 5](#t5-ppa-9-649){ref-type="table"} shows the results of logistic regression analysis of factors associated with nephropathy. Nephropathy was significantly associated with age, BMI, and risk seeking in hypothetical lottery (QE), but not with diabetes type, diabetes duration, or levels of HbA~1c~ at the time of the survey.

Attitude toward hypothetical lottery risk and type of diabetes
--------------------------------------------------------------

Question QE, which was associated with both retinopathy and nephropathy, is a standard question that asks patients about certainty equivalents for uncertain benefits.[@b14-ppa-9-649],[@b15-ppa-9-649] Questions QE (lottery 1 low risk, low gain) and QF (lottery 2 high risk, high gain) evaluate the ability to accurately understand the question and the ability to estimate the risk quantitatively (mathematical literacy) and are designed to assess attitudes toward risk. Mathematical expectation in both situations is 1,000 yen (USD 10). The responses to these questions ranged widely from 0 yen to 100,000 yen (USD 1,000) in patients with type 1 diabetes and from 0 yen to 50,000 yen (USD 500) in patients with type 2 diabetes ([Figure 1](#f1-ppa-9-649){ref-type="fig"}). The mean values of patients' pricing were not significantly different between patients with type 1 and type 2 diabetes, but the variances were not the same. Therefore, we performed detailed analysis of the responses to questions QE and QF comparing type 1 with type 2 diabetes. Patients who responded ≤1,000 yen (USD 10) to both QE and QF were categorized as risk averse. Patients who responded \>1,000 yen, do not know, or provided no answer were categorized as risk seeking or no answer. We also categorized the answer zero as risk seeking or no answer, because the answer zero is similar to do not know or no answer rather than reflecting strong risk aversion.[@b14-ppa-9-649] The results are shown in [Table 6](#t6-ppa-9-649){ref-type="table"}. Frequency analysis using Fisher's exact test revealed that a significantly higher proportion of patients with type 1 diabetes were categorized as risk averse compared with patients with type 2 diabetes (*P*\<0.05).

Discussion
==========

Over the past two decades, great advances have been made in the spectrum of pharmacologic agents and monitoring technology available for the treatment of diabetes.[@b16-ppa-9-649] However, the metabolic control of diabetes is still difficult in some patients; as a result, these patients are at a risk of developing end-stage complications. Hinata et al reported that metabolic control in male prisoners with type 2 diabetes improved during imprisonment in Japan.[@b17-ppa-9-649] Although this finding demonstrates that intensive lifestyle interventions are highly effective for the control of diabetes, it also suggests that maintaining a well-regulated lifestyle is difficult in an unrestricted person. The behavioral economics approach has recently attracted much attention as a possible method to improve public health. This approach could be applied to the treatment of patients with diabetes. However, some investigators are critical of the approach because it has not been scientifically supported by solid evidence.[@b18-ppa-9-649] Although there are some reports investigating time preference and health behavior in patients with diabetes,[@b19-ppa-9-649],[@b20-ppa-9-649] analysis of more detailed clinical data is necessary to clarify the trait of health behavior in patients with diabetes. This is the first report that investigated patients with diabetes in a clinical setting using a method based on behavioral economics.

Our survey of patients with diabetes suggests that the attitude of patients toward risk is a significant factor in the progression of diabetic complications. We found that hypothetical lottery risk estimation (QE), myopic time preference (QH), willingness to pay for preventive medicine (QM), and levels of satisfaction with life (QN) showed statistically significant associations with diabetic retinopathy. QN is a supplemental question, and it appears reasonable that patients with diabetes having complications are not satisfied with their life. The results of myopic time preference (QH) appear to indicate that patients without retinopathy prefer an immediate reward (answering high price to QH). However, it is possible that patients considered the question as a choice between sure (immediate) gain and uncertain (future) gain, not as a temporal discounting.[@b9-ppa-9-649] The question may not be suitable for eliciting information on myopic preference, and further studies will be necessary. Willingness to pay for medicine appears to be an important factor. One of the new findings of this study is that patients with diabetes who are willing to pay less for preventive medicine tend to develop retinopathy. QC and QD are questions developed by Ikeda et al[@b11-ppa-9-649],[@b12-ppa-9-649] and are designed to estimate inclination toward procrastination, which indicates hyperbolic discounting for future payoffs and is reported to be associated with BMI. In the present study, we did not find any association between BMI and QC or QD. This discrepancy may reflect the difference between the general population and patients with diabetes; however, further studies are necessary.

Logistic regression analysis indicated that patients who were risk seeking in the estimation of hypothetical lotteries (QE) were prone to develop complications. There are several methods to induce risk preference using lotteries, including binary lotteries or computerized risk tasks.[@b21-ppa-9-649]--[@b23-ppa-9-649] Although these methods are useful for analysis of risk preference, they have typically been used to investigate students or traders who have a high level of literacy proficiency. Our preliminary study revealed that patients with type 2 diabetes found it difficult to understand these methods. Therefore, we used a simple pricing method. Because of the free answer method, there was, unexpectedly, a wide range of responses to the hypothetical lottery question ([Figure 1](#f1-ppa-9-649){ref-type="fig"}). Some patients suggested that they would pay more for a ticket than they could win. Therefore, our results are limited by the fact that we could not differentiate patients who were risk seeking from those with lower quantitative literacy proficiency. On the other hand, recent experimental studies suggest that people with low cognitive ability are more likely to engage in risky behavior, such as committing crimes and smoking, and are more likely to be involved in out-of-wedlock births.[@b10-ppa-9-649],[@b24-ppa-9-649] Therefore, these two factors may be closely related.

As shown in [Table 4](#t4-ppa-9-649){ref-type="table"}, type of diabetes (type 1) and risk averse in lottery risk estimation (answering low price to QE) is negatively associated with retinopathy. Detailed analysis of responses to questions QE and QF showed differences between patients with type 1 and type 2 diabetes. A lower proportion of patients with type 2 diabetes were categorized as risk averse compared with patients with type 1 diabetes. Patients categorized as risk seeking or no answer included both those who had a preference for risk seeking and those with lower literacy proficiency, as described in the results (attitude toward hypothetical lottery risk and type of diabetes). It was suggested that high plasma glucose may affect cognitive function in both type 1 and type 2 diabetes.[@b25-ppa-9-649],[@b26-ppa-9-649] Although Cavanaugh et al reported that poor numeracy skills were common in patients with diabetes,[@b27-ppa-9-649] they could not compare patients with type 1 and type 2 diabetes because of poorer glycemic control in patients with type 1 diabetes. In the present study, all patients were referred because they were difficult to treat, and glycemic control was not significantly different between patients with type 1 and type 2 diabetes at the time of the survey. Therefore, we could compare patients with type 1 and type 2 diabetes.

The results suggest the concept that prototypes of type 1 and type 2 diabetes may be different diseases from the perspective of neuroeconomics. Some patients with type 1 diabetes may have characteristics of neuroeconomics type 2 or some type 2 patients may be miscategorized as neuroeconomics type 1 by the simplified criteria used in this study. Lower quantitative literacy proficiency among patients with type 2 diabetes may not be a result of high glucose but a reflection of the essential pathophysiology of neuroeconomics type 2 diabetes, for example, insulin resistance. The lower response rate among patients with type 2 diabetes may be compatible with this hypothesis. Some patients may have difficulty in estimating risk mathematically because of low literacy proficiency, and it could be that they disregarded the survey. Further studies are necessary to investigate this hypothesis.

In conclusion, we conducted a behavioral economics survey of difficult-to-treat patients with type 1 and type 2 diabetes. This is the first study to apply a survey used in the field of economics to patients with diabetes in a clinical setting. Our survey of patients with diabetes suggests that the attitude of patients toward risk could be a factor in the progression of diabetic complications. We also identified significant differences between patients with type 1 and type 2 diabetes from the perspective of neuroeconomics. Different educational and psychological approaches may be necessary in patients with diabetes based on whether they are risk seeking or risk averse. On the other hand, the present study also highlighted methodological difficulties in behavioral economic surveys of patients with diabetes because of low literacy proficiency in some patients. We could not differentiate patients who were risk seeking from those with low literacy proficiency, although these two factors may be closely related. Furthermore, our results demonstrate that selection bias is inevitable in almost all surveys of patients with diabetes, because those who refuse to participate are excluded and not investigated further. Willingness to participate in a survey is an important personal trait, and selection bias is inevitable in surveys dealing with matters related to personal traits. Further studies are necessary to establish the most suitable form of the survey for estimation of risk preference in patients with diabetes.
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![Box plot of responses to question QE showing quartiles and outliers.\
**Notes:** QE, lottery 1 low risk, low gain. Type 1, 5,823±2,138 (mean ± SE); type 2, 5,064±8,347; difference of the means, Mann--Whitney *U*-test, *P*=0.2805; and difference of variances, standard *F*-test, *P*\<0.0001.\
**Abbreviation:** SE, standard error.](ppa-9-649Fig1){#f1-ppa-9-649}

###### 

Survey questionnaires

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Question label                                                      Construct                                                                                    Text
  ------------------------------------------------------------------- -------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  QA                                                                  General risk proneness 1                                                                     Usually when you go out, how high does the probability of rain have to be before you take an umbrella or take a raincoat with you? More than \[.....\] %.

  QB                                                                  General risk proneness 2                                                                     When you have a seat reservation for a train, how many minutes early do you usually arrive at the station? \[.....\] minutes before.

  QC                                                                  Procrastination 1 (childhood)                                                                Thinking about when you were a child and you were given an assignment during school vacation, how early did you usually finish up the assignment?\
                                                                                                                                                                   1. I tended to get it done early, before the due date.\
                                                                                                                                                                   2. I worked on it daily, up until the due date.\
                                                                                                                                                                   3. I tended to get it done toward the end.

  QD                                                                  Procrastination 2 (now)                                                                      Thinking about yourself now, if you were given an assignment during school vacation, how early would you finish up the assignment?\
                                                                                                                                                                   1. I would get it done rather early, before the due date.\
                                                                                                                                                                   2. I would work on it daily, up until the due date.\
                                                                                                                                                                   3. I would get it done rather toward the end.

  QE                                                                  Risk proneness                                                                               Suppose that there were a lottery worth 2,000 yen (USD 20) with a 50% chance of winning.

  Lottery 1 (low risk, low gain)                                      What is the most that you would pay for a lottery ticket? I would pay up to \[.....\] yen.   

  QF                                                                  Risk proneness\                                                                              Suppose that there were a lottery worth 100,000 yen (USD 1,000) with a 1% chance of winning. What is the most that you would pay for a lottery ticket? I would pay up to \[.....\] yen.
                                                                      Lottery 2 (high risk, high gain)                                                             

  QG                                                                  Endowment effect                                                                             You happen to find a ticket for a lottery with a 1% chance of winning 100,000 yen (USD 1,000). What's the lowest price you would sell it for? No less than \[.....\] yen.

  QH                                                                  Myopic time preference 1                                                                     Let's assume you have two options to receive money. You may choose either receive 20,000 yen today or to receive a different amount 1 month from today. What is the lowest amount of money you would choose to receive 1 month from today, rather than receive 20,000 yen today. I would wait 1 month to receive the 20,000 yen (USD 200) if at least \[.....\] yen were added to it.

  QI                                                                  Myopic time preference 2                                                                     How about if the amount you could receive today is 100,000 yen? What is the lowest amount of money you would choose to receive 1 month from today, rather than receive 100,000 yen today.\
                                                                                                                                                                   I would wait 1 month to receive the 100,000 yen (USD 1,000) if at least \[.....\] yen were added to it.

  QJ                                                                  Acceptance to uncertainty in effectiveness of medicine                                       A doctor tells you that the effectiveness of the medicine they are prescribing can vary among individuals, and that it may or may not end up working for your ailment. Would this explanation be sufficient for you?

  1\. Yes 2. Probably 3. Not sure 4. Probably not 5. No                                                                                                            

  QK                                                                  Average spending on medical care                                                             On average, how much do you spend on medical treatments every month?\
                                                                                                                                                                   Monthly average: \[.....\] yen.

  QL                                                                  Subjective risk estimation for cardiovascular disease (CVD)                                  Out of 100 people including yourself, how many of them do you think will have a heart attack or stroke within 10 years that makes you think you will also have a heart attack or stroke?\
                                                                                                                                                                   \[.....\] people out of 100.

  QM                                                                  Willingness to pay for a medicine reducing disease risk                                      Out of 100 people including yourself, say that 50 of them will have a heart attack or stroke within 10 years. A certain kind of medicine can reduce that number to 25. How much would you pay every month to continue taking that medicine?\
                                                                                                                                                                   I would pay up to \[.....\] yen every month just for that medicine.

  QN                                                                  General satisfaction to current life                                                         How satisfied are you with your current life?

  1\. Very 2. Above average 3. Moderately 4. Not much 5. Not at all                                                                                                

  QO                                                                  Consciousness of disease                                                                     Do you have diabetes?

  1\. Yes 2. No 3. Not sure                                                                                                                                        

  QP                                                                  Patient understanding of diabetes                                                            Which of the following do you think most apply as factors in diabetes getting worse?\
                                                                                                                                                                   1. Lifestyle is a greater factor than genetics.\
                                                                                                                                                                   2. Lifestyle and genetics are roughly equal factors.\
                                                                                                                                                                   3. Genetics are a greater factor than lifestyle.

  QQ                                                                  Family understanding of diabetes                                                             The next question is only for diabetes patients.\
                                                                                                                                                                   Does your family tell you that you have diabetes or your diabetes got worse because of your lifestyle?

  1\. Yes 2. Maybe 3. No 4. I do not live with family                                                                                                              
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Age-stratified patient characteristics

                               Type 1      Type 2      *P*-value
  ---------------------------- ----------- ----------- -----------
  Age under 45                                         
   Number of patients          32          17          
   Age (years)                 36.3±1.1    37.6±1.5    0.4547
   Male:female                 10:22       11:6        0.0351
   BMI (kg/m^2^)               23.9±0.8    25.8±1.1    0.1694
   Diabetes duration (years)   11.3±1.4    5.6±1.8     0.0173
   HbA~1c~ (% NGSP)            7.57±0.23   7.92±0.31   0.3671
   Nephropathy rate (%)        9.8         23.5        0.1934
   Retinopathy rate (%)        32.3        29.4        0.8388
   Insulin treatment (%)       96.8        91.7        0.1870
  Age 45--under 65                                     
   Number of patients          22          76          
   Age (years)                 54.7±1.2    56.8±0.7    0.1280
   Male:female                 11:11       49:27       0.2198
   BMI (kg/m^2^)               22.7±0.9    26.4±0.5    0.0005
   Diabetes duration (years)   10.4±1.3    10.3±0.7    0.9302
   HbA~1c~ (% NGSP)            7.48±0.26   7.57±0.14   0.7871
   Nephropathy rate (%)        13.6        38.2        0.0308
   Retinopathy rate (%)        18.1        56.8        0.0015
   Insulin treatment (%)       90.9        60.0        0.0247
  Age 65 or older                                      
   Number of patients          12          60          
   Age (years)                 70.5±1.5    71.5±0.7    0.5399
   Male:female                 7:5         35:25       1.0000
   BMI (kg/m^2^)               23.7±1.2    24.9±0.6    0.3858
   Diabetes duration (years)   20.0±3.1    14.8±1.4    0.1057
   HbA~1c~ (% NGSP)            7.49±0.38   7.29±0.16   0.6261
   Nephropathy rate (%)        43.3        52.4        0.4822
   Retinopathy rate (%)        33.3        46.5        0.4014
   Insulin treatment (%)       25.0        43.0        0.2372

**Note:** Values are presented as mean ± SE.

**Abbreviations:** BMI, body mass index; HbA~1c~, hemoglobin A~1c~; NGSP, National Glycohemoglobin Standardization Program; SE, standard error.

###### 

Age-stratified analysis of the survey response rate

                                   Type 1 diabetes                                     Type 2 diabetes                                    
  -------------------------------- --------------------------------------------------- ----------------- ------- --- ------- ---- ------- ----
  Patients number by age                                                                                                                  
   Under 45                        7                                                   3                 20      2   5       6    5       1
   45--under 65                    11                                                  0                 10      1   31      18   19      8
   65 or older                     6                                                   1                 4       1   29      6    21      4
  Total patient number             24                                                  4                 34      4   65      30   45      13
  Response rate by sex             85.7%                                                                 89.5%       68.4%        77.6%   
  Response rate by diabetes type   87.9%[\*\*](#tfn3-ppa-9-649){ref-type="table-fn"}                                 71.9%                

**Notes:**

Type 1 vs type 2, *P*\<0.01 for Mantel--Haenszel analysis.

###### 

Ordinal logistic regression analysisa of factors associated with retinopathy levels[b](#tfn5-ppa-9-649){ref-type="table-fn"}

  Parameter                                                   Estimate     Standard error   Chi-square test   *P*-value[e](#tfn8-ppa-9-649){ref-type="table-fn"}
  ----------------------------------------------------------- ------------ ---------------- ----------------- ----------------------------------------------------
  Type (type 1)                                               −0.844       0.371            5.16              0.0232[f](#tfn9-ppa-9-649){ref-type="table-fn"}
  Sex (male)                                                  0.311        0.269            1.33              0.248
  Age                                                         −0.0122      0.0237           0.27              0.6052
  Diabetes duration                                           0.124        0.0336           13.7              0.0002[g](#tfn10-ppa-9-649){ref-type="table-fn"}
  HbA~1c~[c](#tfn6-ppa-9-649){ref-type="table-fn"}            0.631        0.219            8.28              0.004[g](#tfn10-ppa-9-649){ref-type="table-fn"}
  BMI                                                         −0.0566      0.0734           0.59              0.4407
  Survey responses[d](#tfn7-ppa-9-649){ref-type="table-fn"}                                                   
   QA: general risk proneness 1                               −0.000605    0.0124           0                 0.9611
   QB: general risk proneness 2                               −0.0106      0.0214           0.25              0.6195
   QC\[1\]: procrastination 1                                 −0.508       0.513            0.98              0.3223
   QC\[2\]                                                    0.998        0.537            3.44              0.0635
   QE: lottery 1 low risk, low gain                           0.0000906    0.0000321        7.98              0.0047[g](#tfn10-ppa-9-649){ref-type="table-fn"}
   QG: endowment effect                                       0.0000114    0.00000869       1.73              0.1884
   QH: myopic time preference 1                               −0.0000482   0.0000205        5.52              0.0188[f](#tfn9-ppa-9-649){ref-type="table-fn"}
   QJ\[2/1\]: accept uncertainty                              −0.794       0.679            1.37              0.2423
   QJ\[3/2\]                                                  0.460        0.789            0.34              0.5602
   QJ\[4/3\]                                                  −1.86        1.19             2.43              0.1192
   QJ\[5/4\]                                                  2.97         1.65             3.25              0.0714
   QK: medical spending                                       0.0000361    0.0000278        1.69              0.194
   QL: subjective CVD risk                                    0.00658      0.0144           0.21              0.6484
   QM: willingness to pay                                     −0.0000964   0.0000361        7.11              0.0077[g](#tfn10-ppa-9-649){ref-type="table-fn"}
   QN\[2/1\]: life satisfaction                               5.78         1.46             15.54             \>0.0001[g](#tfn10-ppa-9-649){ref-type="table-fn"}
   QN\[3/2\]                                                  −1.49        0.660            5.1               0.0239[f](#tfn9-ppa-9-649){ref-type="table-fn"}
   QN\[4/3\]                                                  −0.554       0.827            0.45              0.5023
   QN\[5/4\]                                                  2.04         1.45             1.98              0.1591
   QO\[1\]: DM consciousness                                  3.35         1,715            0                 0.9984
   QO\[2\]                                                    −10.9        3,431            0                 0.9975
   QP\[2/1\]: patient understanding                           0.773        0.589            1.72              0.1895
   QP\[3/2\]                                                  0.466        1.13             0.17              0.6823
   QQ\[1\]: family understanding                              3.49         597              0                 0.9953
   QQ\[2\]                                                    5.36         597              0                 0.9928
   QQ\[3\]                                                    3.60         597              0                 0.9952

**Notes:**

Whole model test: degrees of freedom 31, likelihood-ratio χ^2^ test 82.79, and *P*-value \<0.0001.

Levels of diabetic retinopathy: 0 NDR, 1 SDR, 2 PPDR, and 3 PDR/PRP.

HbA~1c~ at the time of survey.

Survey questionnaires are shown in [Table 1](#t1-ppa-9-649){ref-type="table"}.

Wald test for effects.

*P*\<0.05, significant by effect likelihood-ratio test.

*P*\<0.01, significant by effect likelihood-ratio test.

**Abbreviations:** BMI, body mass index; CVD, cardiovascular disease; DM, diabetes mellitus; HbA~1c~, hemoglobin A~1c~; NDR, no diabetic retinopathy; SDR, simple diabetic retinopathy; PPDR, preproliferative diabetic retinopathy; PDR/PRP, proliferative diabetic retinopathy including panretinal photocoagulation.

###### 

Nominal logistic regression analysis[a](#tfn12-ppa-9-649){ref-type="table-fn"} of factors associated with nephropathy[b](#tfn13-ppa-9-649){ref-type="table-fn"}

  Parameter                                                    Estimate     Standard error   Chi-square test   *P*-value[e](#tfn16-ppa-9-649){ref-type="table-fn"}
  ------------------------------------------------------------ ------------ ---------------- ----------------- -----------------------------------------------------
  Type (type 1)                                                −0.294       0.391            0.57              0.4516
  Sex (male)                                                   0.681        0.357            3.63              0.0567
  Age                                                          0.0880       0.0305           8.28              0.004[g](#tfn18-ppa-9-649){ref-type="table-fn"}
  Diabetes duration                                            0.0341       0.0378           0.81              0.3676
  HbA~1c~[c](#tfn14-ppa-9-649){ref-type="table-fn"}            −0.00612     0.270            0                 0.9819
  BMI                                                          0.234        0.0966           5.9               0.0152[f](#tfn17-ppa-9-649){ref-type="table-fn"}
  Survey responses[d](#tfn15-ppa-9-649){ref-type="table-fn"}                                                   
   QA: general risk proneness 1                                0.00103      0.0150           0                 0.9453
   QB: general risk proneness 2                                −0.00782     0.0232           0.11              0.7369
   QC\[1\]: procrastination 1                                  −0.0149      0.624            0                 0.9809
   QC\[2\]                                                     −0.865       0.647            1.78              0.1816
   QE: lottery 1 low risk, low gain                            0.0000761    0.0000335        5.15              0.0233[f](#tfn17-ppa-9-649){ref-type="table-fn"}
   QG: endowment effect                                        −0.0000211   0.0000126        2.78              0.0957
   QH: myopic time preference 1                                0.00000562   0.0000207        0.07              0.7867
   QJ\[2/1\]: accept uncertainty                               −1.15        0.743            2.41              0.1205
   QJ\[3/2\]                                                   0.316        0.924            0.12              0.7322
   QJ\[4/3\]                                                   0.590        1.18             0.25              0.6182
   QJ\[5/4\]                                                   −1.42        1.82             0.61              0.4331
   QK: medical spending                                        −0.0000655   0.0000418        2.46              0.1171
   QL: subjective CVD risk                                     0.0100       0.0158           0.4               0.5266
   QM: willingness to pay                                      −0.0000370   0.0000302        1.5               0.2207
   QN\[2/1\]: life satisfaction                                2.63         1.38             3.62              0.0569
   QN\[3/2\]                                                   0.0289       0.723            0                 0.9681
   QN\[4/3\]                                                   −0.0579      0.976            0                 0.9527
   QN\[5/4\]                                                   −1.22        2.40             0.26              0.612
   QO\[1\]: DM consciousness                                   −0.196       140,002          0                 1
   QO\[2\]                                                     −25.0        221,361          0                 0.9999
   QP\[2/1\]: patient understanding                            −0.633       0.610            1.08              0.2992
   QP\[3/2\]                                                   2.33         1.40             2.77              0.0963
   QQ\[1\]: family understanding                               −0.348       0.689            0.25              0.6138
   QQ\[2\]                                                     1.40         0.786            3.2               0.0737
   QQ\[3\]                                                     −1.39        0.730            3.66              0.0558

**Notes:**

Whole model test: degrees of freedom 31, likelihood-ratio χ^2^ test 59.22, *P*-value 0.0017.

Nephropathy was defined as urinary albumin excretion ≥30 mg/g creatinine.

HbA~1c~ at the time of survey.

Survey questionnaires are shown in [Table 1](#t1-ppa-9-649){ref-type="table"}.

Wald test for effects.

*P*\<0.05, significant by effect likelihood ratio test.

*P*\<0.01, significant by effect likelihood ratio test.

**Abbreviations:** BMI, body mass index; CVD, cardiovascular disease; DM, diabetes mellitus; HbA~1c~, hemoglobin A~1c~.

###### 

Attitude to risk assessed by responses to a hypothetical lottery estimation (QE and QF)[a](#tfn21-ppa-9-649){ref-type="table-fn"}

  Attitude to risk                       Type 1 diabetes                                        Type 2 diabetes                                                                                                                         
  -------------------------------------- ------------------------------------------------------ ----------------- ------------------------------------------------------ ----------------- ------------- ---------------- ------------- ----------------
  Mean response to QE (JPY) (SD)         472 (397)                                              10,300 (15,195)   578 (349)                                              10,970 (23,308)   641 (344)     7,313 (11,885)   512 (422)     5,924 (4,846)
  Mean response to QF (JPY) (SD)         690 (72)                                               5,800 (637)       657 (377)                                              12,466 (25,385)   735 (351)     8,565 (16,427)   437 (370)     7,268 (11,880)
  Mean age (SD)                          52.6 (12.8)                                            52.1 (15.0)       43.3 (13.7)                                            49.5 (12.9)       63.9 (10.3)   61.6 (10.8)      54.1 (23.2)   62.1 (10.8)
  Patients number by age                                                                                                                                                                                                                
   Under 45                              3                                                      4                 10                                                     10                1             4                4             1
   45--under 65                          6                                                      5                 3                                                      7                 6             25               0             19
   65 or older                           2                                                      4                 1                                                      3                 10            19               4             17
  Total patients number (% in the sex)   11[c](#tfn23-ppa-9-649){ref-type="table-fn"} (45.8%)   13 (54.2%)        14[c](#tfn23-ppa-9-649){ref-type="table-fn"} (41.2%)   20 (58.8%)        17 (26.2%)    48 (73.8%)       8 (17.8%)     37 (82.2%)

**Notes:** QE, lottery 1 low risk, low gain; QF, lottery 2 high risk, high gain.

Questionnaires QE and QF are shown in [Table 1](#t1-ppa-9-649){ref-type="table"}.

Risk seeking or no answer includes the zero-answers.

Prevalence of risk averse category was higher in patients with type 1 diabetes compared with patients with type 2 diabetes (*P*\<0.05).

**Abbreviation:** SD,standard deviation.
